Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Celgene (United States)
h-index: 0
Total citations: 0
Total papers: 0
Homepage:
https://www.celgene.com/
Recent papers from Celgene (United States)
Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity
Neurobiology of Aging · 2018
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients
Lara D. Veeken · 2021
First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial
Cancer Management and Research · 2019
Effect of concomitant vancomycin and piperacillin–tazobactam on frequency of acute kidney injury in pediatric patients
American Journal of Health-System Pharmacy · 2019
Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects
The Journal of Clinical Pharmacology · 2019
Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder
npj Parkinson s Disease · 2019
Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients
Haematologica · 2018
nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial
OncoTargets and Therapy · 2017
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma · 2016
A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase
Pain Medicine · 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial
Blood Cancer Journal · 2016
CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer
Annals of Oncology · 2016
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohnʼs Disease
Inflammatory Bowel Diseases · 2015
Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice in Relapsed/Refractory Mantle Cell Lymphoma: Results of the MCL-002 (SPRINT) Study
Blood · 2014
Lenalidomide Promotes Degradation of Casein Kinase 1a (CK1a) through Cereblon: Implications for the Efficacy of Lenalidomide in MDS and AML
Blood · 2014
Overall Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) with >30% Bone Marrow Blasts Treated with Azacitidine By Cytogenetic Risk Status: Results of the AZA-AML-001 Study
Blood · 2014
Nonhematologic Toxicity of Imatinib Mesylate in Pediatric Patients With Chronic Myelogenous Leukemia
Journal of Pediatric Hematology/Oncology · 2014
Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis
Journal of Medical Economics · 2014
Multi-regional clinical trial design and consistency assessment of treatment effects
Statistics in Medicine · 2014
Derivatization of genotoxic nitroaromatic impurities for trace analysis by LC-MS
Analytical Methods · 2014